Pharmaceutical giant Pfizer develops and produces medicines and vaccines for a variety of chronic diseases and conditions. The company, founded in 1872, has several blockbuster products that each generate more than $1 billion in revenue per year, including Prevnar 13, a pneumococcal conjugate vaccine; Ibrance, a breast cancer treatment; and Eliquis, which helps prevent strokes in at-risk people. On Dec. 11, 2020, to help combat the coronavirus pandemic, the U.S. Food and Drug Administration authorized Pfizer and BioNTech’s COVID-19 vaccine for emergency use, the first of three given a green light in the U.S. As of May 26, half of all adults in the U.S. have been fully vaccinated against COVID-19, in large part due to the Pfizer-BioNTech shot.
Lists ranking Pfizer
Latest news for Pfizer
- HealthPfizer is on the hunt for new blockbuster drugs, backed by its COVID fortuneNovember 8, 2022 2:15 PM UTC
- EuropeEurope’s drug regulator set to approve Moderna and Pfizer Omicron boosters this weekAugust 31, 2022 4:09 PM UTC
- NewslettersHow Zoetis’s CEO is catering to the hands-on millennial pet ownerAugust 30, 2022 12:16 PM UTC
- HealthPfizer-BioNTech ‘surprised’ by Moderna lawsuit alleging they copied COVID-19 vaccine technologyAugust 26, 2022 4:09 PM UTC